{"url_path":"/sec/fenc/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1211583/0001104659-26-061213-index.html","accession_number":"0001104659-26-061213","cik":"0001211583","ticker":"FENC","issuer_name":"FENNEC PHARMACEUTICALS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1211583/0001104659-26-061213-index.html","primary_entity_key":"0001211583","primary_entity_name":"FENNEC PHARMACEUTICALS INC."},"word_count":101,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors**\n\nOur Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 27, 2026 (the “Annual Report”), includes a detailed discussion of our risk factors under the heading “PART I, Item 1A – Risk Factors.” You should carefully consider the risk factors discussed in our Annual Report, as well as other information in this Quarterly Report. Any of these risks could cause our business, financial condition, results of operations and future growth prospects to suffer. We are not aware of any material changes from the risk factors previously disclosed."}